Filing Details

Accession Number:
0001179110-20-009968
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-09-28 07:48:17
Reporting Period:
2020-09-24
Accepted Time:
2020-09-28 07:48:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1634432 Strongbridge Biopharma Plc SBBP () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1106519 N David Gill 900 Northbrook Drive
Suite 200
Trevose PA 19053
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2020-09-24 8,000 $2.13 74,896 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased on the open market in multiple transactions at prices ranging from $2.13 to $2.14, inclusive. The Reporting Person undertakes to provide to the Issuer, to any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.